Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5S ribosomal RNA pseudogenes, like RNA5SP52, are genomic DNA sequences derived from the 5S rRNA gene that have lost their ability to encode a functional RNA or contribute to the structure or biogenesis of ribosomes. Unlike the canonical 5S rRNA, which is essential for the large ribosomal subunit and for accurate protein translation, pseudogenes are generally transcriptionally silent or produce non-functional noncoding RNAs. However, some 5S rRNA pseudogenes can be transcribed, and emerging research suggests a subset may have regulatory roles in processes such as immune response—although there is no evidence RNA5SP52 itself has any specific function or clinical relevance. There is no evidence of RNA5SP52 being a therapeutic target or relevant biomarker, nor is there evidence of disease association or drug interaction. It is not to be confused with RPSAP52, which is a distinct, transcribed pseudogene with documented roles in cancer.
None established
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5S ribosomal RNA pseudogene 52 (RNA5SP52).